{
  "retracted": false,
  "timestamp": 1546560000000,
  "updates": [
    {
      "timestamp": 1550538543763,
      "identifier": {
        "doi": "10.1371/journal.pone.0210593"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1371/journal.pone.0164646"
  },
  "journal": "PLOS ONE",
  "publisher": "Public Library of Science (PLoS)",
  "title": "Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study"
}
